Prothena Corp PLC
(NASDAQ:PRTA)
$55.55
At close: Feb 2
$55.55
PreMarket: 4:17PM EDT
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range21.060 - 66.470Open / Close- / -Float / Outstanding22.487M / 51.627M
Vol / Avg.0 / 569.882KMkt Cap2.868BP/E-50d Avg. Price57.490
Div / Yield (Forward)- / -%Payout Ratio-Total Float22.487MEPS-3.430
Globe Newswire - Mar 21, 2022, 4:05PM
TalkMarkets - Dec 22, 2022, 7:55AM
InvestorPlace - Sep 28, 2022, 12:52PM
TipRanks - Sep 28, 2022, 8:45AM
Sector: Health Care.Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS-0.410

(EXPECTED) 2023-02-16

REV31.570M
Q3 2022Est.ActualSurprise
EPS-0.530-0.970 -0.4400
REV22.060M1.517M-20.543M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prothena Corp's (PRTA) competitors?

Q

What is the target price for Prothena Corp (PRTA) stock?

A

The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.